MeSH term
Frequency | Condition_Probility | Animals | 13 | 0.0 |
Blotting, Northern | 3 | 0.0 |
Blotting, Western | 5 | 0.0 |
Chromatography, Affinity | 4 | 0.0 |
EF Hand Motifs | 4 | 36.0 |
Electrophoresis, Polyacrylamide Gel | 3 | 0.0 |
Precipitin Tests | 3 | 0.0 |
Protein Binding | 2 | 0.0 |
Rats | 5 | 0.0 |
Research Support, Non-U.S. Gov't | 36 | 0.0 |
S100 Proteins/*metabolism | 4 | 7.0 |
Amino Acid Sequence | 13 | 0.0 |
Base Sequence | 7 | 0.0 |
Calcium-Binding Proteins/genetics/*metabolism | 2 | 8.0 |
Cells, Cultured | 3 | 0.0 |
Humans | 45 | 0.0 |
Molecular Sequence Data | 13 | 0.0 |
RNA, Messenger/metabolism | 2 | 0.0 |
Reverse Transcriptase Polymerase Chain Reaction | 5 | 0.0 |
Sequence Analysis, DNA | 3 | 0.0 |
Neutrophils/*metabolism | 2 | 1.0 |
S100 Proteins/*blood | 4 | 9.0 |
Binding Sites | 5 | 0.0 |
Cloning, Molecular | 2 | 0.0 |
Comparative Study | 7 | 0.0 |
Crystallization | 3 | 1.0 |
Crystallography, X-Ray | 4 | 0.0 |
Models, Molecular | 6 | 0.0 |
Protein Conformation | 4 | 0.0 |
*S100 Proteins | 11 | 14.0 |
Calcium/*metabolism | 2 | 0.0 |
Calgranulin B | 5 | 13.0 |
Dimerization | 6 | 0.0 |
Electrostatics | 2 | 1.0 |
Molecular Weight | 2 | 0.0 |
S100 Proteins/*chemistry/*metabolism | 2 | 25.0 |
Sequence Alignment | 3 | 0.0 |
Calcium-Binding Proteins/*metabolism | 2 | 2.0 |
Cattle | 4 | 0.0 |
Lung/chemistry | 2 | 7.0 |
Recombinant Proteins/metabolism | 3 | 0.0 |
Sequence Homology, Amino Acid | 6 | 0.0 |
Calcium/metabolism | 2 | 0.0 |
Enzyme Activation/drug effects | 2 | 0.0 |
Aged | 5 | 0.0 |
Female | 13 | 0.0 |
*Gene Expression Profiling | 2 | 0.0 |
Male | 13 | 0.0 |
Middle Aged | 6 | 0.0 |
Neoplasm Proteins/biosynthesis/genetics | 2 | 1.0 |
Oligonucleotide Array Sequence Analysis | 3 | 0.0 |
Calgranulin A | 4 | 10.0 |
Chemotaxis/*drug effects | 2 | 4.0 |
Lipopolysaccharides/pharmacology | 2 | 0.0 |
Mice | 5 | 0.0 |
Rabbits | 2 | 0.0 |
Cell Line | 2 | 0.0 |
Granulocytes/*metabolism | 2 | 5.0 |
Recombinant Proteins/chemistry/metabolism | 2 | 0.0 |
Transfection | 2 | 0.0 |
Chromatography, High Pressure Liquid | 4 | 0.0 |
Spectrum Analysis, Mass | 2 | 0.0 |
Gene Expression Profiling | 3 | 0.0 |
Immunohistochemistry | 3 | 0.0 |
Neutrophils/metabolism | 4 | 2.0 |
S100 Proteins/genetics/*metabolism | 2 | 11.0 |
Adult | 8 | 0.0 |
Aged, 80 and over | 2 | 0.0 |
Cytokines/*genetics/metabolism | 2 | 12.0 |
Flow Cytometry | 2 | 0.0 |
Organ Specificity | 2 | 0.0 |
S100 Proteins/*physiology | 2 | 66.0 |
Gene Expression Regulation, Neoplastic | 2 | 0.0 |
RNA, Messenger/analysis | 3 | 0.0 |
DNA, Complementary | 2 | 0.0 |
Biological Markers/analysis | 3 | 0.0 |
Severity of Illness Index | 2 | 0.0 |
Child | 4 | 0.0 |
Child, Preschool | 4 | 0.0 |
Infant | 4 | 0.0 |
Risk Factors | 2 | 0.0 |
Chromosome Mapping | 2 | 0.0 |
Tumor Cells, Cultured | 2 | 0.0 |
Enzyme-Linked Immunosorbent Assay | 5 | 0.0 |
Adolescent | 3 | 0.0 |
Immunohistochemistry/methods | 2 | 0.0 |
Host-Parasite Relations | 2 | 5.0 |